Delivery Order SPE2DB25D3012-SPE2DB25FWWKE

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,817.16 firm-fixed-price delivery order is for the supply of 4,564,816,082 units of the pharmaceutical drug Mestinon 60 mg tablets. The contract has an ultimate completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $5,475.69 with a completion date of January 9, 2025. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This federal contract award, valued at $12,756.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025. The contract covers the procurement of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,047.18 firm fixed-price delivery order is for MESTINON 180 MG TIMESPAN UU 30S medication, with a period of performance through November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, worth $18,728.40, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Mestinon 180 mg TimeSpan medication. This is a firm fixed-price delivery order contract with a completion date of May 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $3,732.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. It is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,691.14, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,395.46 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat certain neurological conditions. The award has an ultimate completion date of January 28, 2025 and is not associated with a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,737.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Mestinon 180 mg Timespan medication. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.77, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. This contract award is not associated with a set-aside designation....
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWWKE
    Delivery Order

This federal contract award, valued at $14,608.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of MESTINON 60 MG TABLET 100S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.

Generated 6/24/25, 9:56 AM